From Bioinicia Fluidnatek, we would like to invite you to our highly informative Webinar in collaboration with the 3Bs-University of Minho.
Date: June 18th, 2025
Time: 5 p.m. CET / 11 a.m. ET / 8 a.m. PT.
Click here to register
Abstract
To mimic the structure and function of natural extracellular matrix (ECM), electrospun fibrous meshes (eFMs) have been developed at the 3B’s Research Group (University of Minho, Portugal). Despite their physical resemblance, the ability of natural ECM to locally bind, store and deliver bioactive factors to adjacent cells have been also considered. Materializing, antibodies, tissue-specific proteins, soluble growth factors or extracellular vesicles were immobilized at the high surface area of eFMs. These biofunctional systems were developed to specifically regenerate cartilage, bone, vascular, neural and thymic tissues, using either endogenous or natural biomolecules. Ultimately, we aim to validate, at the preclinical and clinical stages, advanced target therapies for human use.
About the speaker
Dr. Albino Martins is an expert in Tissue Engineering and Regenerative Medicine at 3Bs – University of Minho, with expertise in nanostructures for targeted therapies. He holds a PhD in Tissue Engineering and has authored over 85 publications, accumulating 4,000+ citations (h-index 36). His work focuses on functionalized nanofibers and nanoparticles for cell modulation and cancer treatment. He has led and coordinated several national and international research projects, holds multiple patents, and actively participates in scientific dissemination. Martins also serves on editorial boards of high-impact journals and has supervised numerous graduate students, contributing significantly to research, innovation, and education in biomaterials and regenerative medicine.
About 3B’s
The 3B’s Research Group, part of the 3Bs Institute at the University of Minho, Portugal, is a leading center in biomaterials, tissue engineering, and regenerative medicine. Established in 1998, it focuses on developing natural polymer-based biomaterials and stem cell therapies for applications in drug delivery and tissue regeneration. The group leads the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, with branches in 13 countries.